Associated Papers
CD137 deficiency because of two novel biallelic TNFRSF9 mutations in a patient presenting with severe EBV-associated lymphoproliferative disease.
Shen K et al.
Clinical & Translational Immunology, 2023
37144041 (PubMed )
Supplement: CTI2-12-e1448-s001.pdf
Select a paper to view details